The mechanism of action of tissue plasminogen activator is
Inhibits platelet aggregation
Enhance fibrin degradation
Inhibit clot formation
Tissue Plasminogen Activator (tPA) is a serine protease involved in the breakdown of blood clots. It plays a vital role in the thrombolytic or fibrinolytic process, helping to convert plasminogen to plasmin. Plasmin is an enzyme that breaks down fibrin, a protein involved in blood clotting. Therefore, tPA enhances fibrin degradation.
Here's how it works:
This mechanism highlights the thrombolytic function of tPA, primarily used in clinical settings to treat acute ischemic strokes, myocardial infarctions, and pulmonary embolisms by dissolving the clots that block blood flow. Thus, the correct answer to the question regarding tPA's mechanism of action is:
Other options such as "Inhibit extrinsic pathway," "Inhibits platelet aggregation," and "Inhibit clot formation" do not accurately describe the primary mechanism of action of tPA.
The primary source of energy for Earth’s climate system is:
The most common site of metastasis for breast cancer is:
Which of the following cranial nerves is responsible for the motor innervation of the muscles of mastication?
Which of the following is a characteristic feature of Parkinson’s disease?
Which enzyme is deficient in Gaucher’s disease?